Cover Image
市場調查報告書

Torrent Pharmaceuticals Limited:產品平台分析

Torrent Pharmaceuticals Limited - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 256035
出版日期 內容資訊 英文 36 Pages
訂單完成後即時交付
價格
Back to Top
Torrent Pharmaceuticals Limited:產品平台分析 Torrent Pharmaceuticals Limited - Product Pipeline Review - 2015
出版日期: 2015年09月09日 內容資訊: 英文 36 Pages
簡介

Torrent Pharmaceuticals Limited 是印度的代表性製藥公司,製造品牌及學名藥,在全球展開。尤其是致力於心臟血管、中樞神經系統、腸胃系統、糖尿病學、抗感染藥,及疼痛管理的領域的醫藥品。還有投藥形態上也製造藥丸、膠囊、非口服等各種醫藥品有效成分(APIs)。

本報告提供Torrent Pharmaceuticals Limited 的治療藥開發平台的現狀及各開發階段比較分析、藥物標的、作用機制、給藥途徑、各分子類型的治療藥的評估、最新的企業新聞和發表、休止的計劃相關資訊等。

Torrent Pharmaceuticals Limited的基本資料

  • Torrent Pharmaceuticals Limited概要
  • 主要資訊
  • 企業資料

Torrent Pharmaceuticals Limited:R&D概要

  • 主要的治療範圍

Torrent Pharmaceuticals Limited:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Torrent Pharmaceuticals Limited:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Torrent Pharmaceuticals Limited:藥物簡介

Torrent Pharmaceuticals Limited:開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Torrent Pharmaceuticals Limited:暫停中的計劃

Torrent Pharmaceuticals Limited:企業發表

Torrent Pharmaceuticals Limited:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07557CDB

Summary

Global Markets Direct's, 'Torrent Pharmaceuticals Limited - Product Pipeline Review - 2015', provides an overview of the Torrent Pharmaceuticals Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Torrent Pharmaceuticals Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Torrent Pharmaceuticals Limited including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Torrent Pharmaceuticals Limited's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Torrent Pharmaceuticals Limited's pipeline products

Reasons to buy

  • Evaluate Torrent Pharmaceuticals Limited's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Torrent Pharmaceuticals Limited in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Torrent Pharmaceuticals Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Torrent Pharmaceuticals Limited and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Torrent Pharmaceuticals Limited
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Torrent Pharmaceuticals Limited and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Torrent Pharmaceuticals Limited Snapshot
    • Torrent Pharmaceuticals Limited Overview
    • Key Information
    • Key Facts
  • Torrent Pharmaceuticals Limited - Research and Development Overview
    • Key Therapeutic Areas
  • Torrent Pharmaceuticals Limited - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Torrent Pharmaceuticals Limited - Pipeline Products Glance
    • Torrent Pharmaceuticals Limited - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Torrent Pharmaceuticals Limited - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Torrent Pharmaceuticals Limited - Drug Profiles
    • TRC-150094
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TRC-4186
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TRC-160334
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Antagonize Angiotensin II and Endothelin Receptor-A for Hypertension
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TRC-120038
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TRC-210258
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for COPD
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Neuropathic Pain
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Torrent Pharmaceuticals Limited - Pipeline Analysis
  • Torrent Pharmaceuticals Limited - Pipeline Products by Target
  • Torrent Pharmaceuticals Limited - Pipeline Products by Route of Administration
  • Torrent Pharmaceuticals Limited - Pipeline Products by Molecule Type
  • Torrent Pharmaceuticals Limited - Pipeline Products by Mechanism of Action
  • Torrent Pharmaceuticals Limited - Dormant Projects
  • Torrent Pharmaceuticals Limited - Company Statement
  • Torrent Pharmaceuticals Limited - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Torrent Pharmaceuticals Limited, Key Information
  • Torrent Pharmaceuticals Limited, Key Facts
  • Torrent Pharmaceuticals Limited - Pipeline by Indication, 2015
  • Torrent Pharmaceuticals Limited - Pipeline by Stage of Development, 2015
  • Torrent Pharmaceuticals Limited - Monotherapy Products in Pipeline, 2015
  • Torrent Pharmaceuticals Limited - Phase II, 2015
  • Torrent Pharmaceuticals Limited - Phase I, 2015
  • Torrent Pharmaceuticals Limited - Preclinical, 2015
  • Torrent Pharmaceuticals Limited - Discovery, 2015
  • Torrent Pharmaceuticals Limited - Pipeline by Target, 2015
  • Torrent Pharmaceuticals Limited - Pipeline by Route of Administration, 2015
  • Torrent Pharmaceuticals Limited - Pipeline by Molecule Type, 2015
  • Torrent Pharmaceuticals Limited - Pipeline Products by Mechanism of Action, 2015
  • Torrent Pharmaceuticals Limited - Dormant Developmental Projects,2015
  • Torrent Pharmaceuticals Limited, Other Locations
  • Torrent Pharmaceuticals Limited, Subsidiaries

List of Figures

  • Torrent Pharmaceuticals Limited - Pipeline by Top 10 Indication, 2015
  • Torrent Pharmaceuticals Limited - Pipeline by Stage of Development, 2015
  • Torrent Pharmaceuticals Limited - Monotherapy Products in Pipeline, 2015
  • Torrent Pharmaceuticals Limited - Pipeline by Top 10 Target, 2015
  • Torrent Pharmaceuticals Limited - Pipeline by Top 10 Molecule Type, 2015
  • Torrent Pharmaceuticals Limited - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top